Braithwaite R, Jelovac A, Kellner CH, Sartorius A, Sienaert P, McLoughlin DM. Ketamine versus ECT for major depression: flawed evidence base. Lancet Psychiatry. 2026 13(3):180-182. Epub 2025 Oct 22.
Knabbe J, Sartorius A. Just a Caffeine-Blocker? Questioning New Proposed Core Mechanisms of ECT. Brain Stimul. 2026 19(3):103108. Epub 2026 Apr 25.
Pedraz-Petrozzi B, Marszalek-Grabska M, Fornal E, Wielgosz A, Stachniuk A, Marzec P, Neumann E, Riedinger E, Gilles M, Gründer G, Danyeli LV, Sen ZD, Walter M, Sartorius A, Spangemacher M, Reinwald JR. Kynurenine pathway profiles as markers of ketamine response in treatment-resistant depression. Brain Behav Immun. 2026 Jul 5. [Epub ahead of print] 138:106889.
Weber-Fahr W, Dommke S, Sack MS, Alzein N, Becker R, Demirakca T, Ende G, Schilling C. Reduced ATP-to-phosphocreatine ratios in neuropsychiatric post-COVID condition: Evidence from P magnetic resonance spectroscopy. Biol Psychiatry. 2026 Jan 10. [Epub ahead of print]
Zilles-Wegner D, Wasserman D, Schulze TG, Pogarell O, Miskimen T, Rapaport MH, Summergrad P, Fiorillo A, Arango C, Global Expert Taskforce on ECT Global Expert Taskforce on ECT, Sartorius A. Joint statement by the World Psychiatric Association, the American Psychiatric Association, the European Psychiatric Association, and the Global Expert Task Force on ECT on the portrayal of electroconvulsive therapy in the WHO Guidance on Mental Health Policy and Strategic Action Plans. Lancet Psychiatry. 2026 13(5):441-444. Epub 2026 Mar 31.